BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/31/2024 8:36:36 AM | Browse: 193 | Download: 621
 |
Received |
|
2024-08-24 21:35 |
|
Peer-Review Started |
|
2024-08-24 21:35 |
|
First Decision by Editorial Office Director |
|
2024-09-30 10:49 |
|
Return for Revision |
|
2024-09-30 10:49 |
|
Revised |
|
2024-10-14 11:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-23 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-23 12:55 |
|
Articles in Press |
|
2024-10-23 12:55 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-28 06:01 |
|
Publish the Manuscript Online |
|
2024-10-31 08:01 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed H Laimoud and Ismail R Raslan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed H Laimoud, MD, PhD, Associate Professor, Department of Cardiovascular Critical Care, Prince Sultan Cardiac Center, Makkah Al Mukarramah Br Road, As Sulimaniyah, Riyadh, Riyadh 12611, Saudi Arabia. m.laimoud@cu.edu.eg |
| Key Words |
Heart failure; Cardiovascular risk; Diabetes mellitus; Mortality; Sodium-dependent glucose transporter 2 inhibitors |
| Core Tip |
Grubić Rotkvić et al published an observational study on the use of sodium-dependent glucose transporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus and asymptomatic heart failure. Their findings included reduced cardiac load and improved cardiovascular performance related to the use of SGLT2i. This suggests that SGLT2i are not merely glucose-lowering drugs; they are integral to the broader cardiovascular management in patients with type 2 diabetes mellitus. |
| Publish Date |
2024-10-31 08:01 |
| Citation |
Laimoud MH, Raslan IR. Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure. World J Cardiol 2024; 16(11): 665-668 |
| URL |
https://www.wjgnet.com/1949-8462/full/v16/i11/665.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v16.i11.665 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
